Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Valneva
Sort By
Newest First
Sign in
1 / 1
1 / 1
Biotechs
10 Promising Biotechs Aiming to Transform Medicine
David Alvaro, Ph.D.; Danielle Alvarez
Pharma's Almanac
PA564
Mar 22, 2022
Collaboration
Valneva and IDT Biologika Announce Collaboration for Production of Inactivated COVID-19 Vaccine VLA2001
IDT Biologika
PR-M12-21-02
Dec 15, 2021
Vaccine
Valneva Reports Positive Phase 1/2 Data for Its Inactivated, Adjuvanted COVID-19 Vaccine Candidate, VLA2001
Valneva SE
PR-M04-21-006
Apr 08, 2021
